The growth of the antibacterial susceptibility testing systems market is mainly driven by the growing number of hospitals across major markets, increasing awareness about diagnosis and the treatment of hospital-acquired infections coupled with the increasing adoption of rapid AST methods. Moreover, rising R&D investments by the key players operating in the market to develop genetics and genotyping-based AST solutions coupled with growing funding & grants for AST-related research are other important factors to drive the market growth in the near future.
According to the new market research report Antimicrobial Susceptibility Testing Market is projected to reach USD 4.2 billion by 2025 from USD 3.2 billion in 2020, at a CAGR of 5.5% during the forecast period.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=206359984
Based on type, the antibacterial susceptibility testing systems segment is expected to account for the largest share of the AST Market in 2019
Based on type, the antibacterial susceptibility testing systems market has been segmented into the antibacterial susceptibility testing, antifungal susceptibility testing, antiparasitic susceptibility testing, and susceptibility testing types. Among these, the antibacterial susceptibility testing segment dominated the market in 2019. The major share of the segment is attributed to the presence of regulatory guidelines to streamline the process of antibacterial susceptibility testing, technological advancements, and the rising burden of antibacterial resistance in developing as well as developed countries.
The clinical diagnostics segment is expected to register the highest growth rate during the forecast period
Based on application, the antimicrobial susceptibility testing market has been segmented into the market is segmented into clinical diagnostics, drug discovery and development, epidemiology, and other applications. Significant market growth in the clinical diagnostics segment can be attributed to the rising burden of infectious diseases, the growing burden of antimicrobial resistance, and new product launches in the market.
The susceptibility testing disks subsegment of manual antimicrobial susceptibility testing products to hold major market share by 2025
Based on the product, the antimicrobial susceptibility testing market is segmented into automated laboratory instruments, manual antimicrobial susceptibility testing products, culture and growth media, and consumables. The manual susceptibility testing products segment is further divided into susceptibility testing disks, MIC strips, and susceptibility testing plates. Among the manual antimicrobial susceptibility testing products, the susceptibility testing disks segment held a major share of the market in 2019. The high quality, low cost, and ease of use of these products are increasing the adoption of susceptibility testing disks in emerging countries. Some prominent players offering susceptibility testing disks include BD (US), Thermo Fisher Scientific, Inc. (US), Bio-Rad Laboratories, Inc. (US), and HiMedia Laboratories (India).
North America is expected to dominate the global antibacterial susceptibility testing systems market in 2019
North America, comprising the US and Canada, accounted for the largest share of the antimicrobial susceptibility testing market in 2019. Technological advancements in rapid antimicrobial susceptibility testing systems, rising incidence of infectious diseases (such as AIDS, tuberculosis, and pertussis), and government support for antimicrobial resistance-related research are the major factors driving market growth in North America. As AST through conventional methods is a lengthy process, customers in North America are moving towards rapid AST techniques, which require minimal reagents. This trend will have a positive impact on the automated instruments market.
Request For Report Sample: https://www.marketsandmarkets.com/requestsampleNew.asp?id=206359984
bioMérieux SA (France), Becton, Dickinson and Company (US), Thermo Fisher Scientific (US), Danaher Corporation (US), Bio-Rad Laboratories, Inc. (US), Bruker (US), Roche Diagnostics Limited (Switzerland), Accelerate Diagnostics, Inc. (US), Merck KGaA (US), Hi-Media Laboratories (India), Liofilchem S.r.l. (Italy), Alifax S.r.l. (Italy), Creative Diagnostics (US), Synbiosis (UK), Bioanalyse (Turkey), ZHUHAI DL BIOTECH Co., Ltd. (China), ELITechGroup (France), Mast Group Ltd. (UK), CONDALAB (Spain), Genefluidics, Inc. (US), Biotron Ltd (Australia), InvivoGen (US), MP Biomedicals (US), QuantaMatrix Inc. (South Korea), and PML Microbiologicals Inc. (US), among others are some of the major players operating in the global Antimicrobial Susceptibility Testing Market.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
[email protected]
Antimicrobial Susceptibility Testing Market Top Growth Factors and Future Trends 2025
On the basis of product type, the antimicrobial susceptibility testing market is segmented into instruments, consumables & accessories and services & software.
In 2021, instruments segment is expected to dominate the market due to high technology adoption by key players in the market.On the basis of methods, the antimicrobial susceptibility testing market is segmented into mass spectrometry method, dilution, disk diffusion, e-test, genotypic methods and others.
In 2021, disk diffusion segment is expected to dominate the market due to its accurate, reliable and efficient results.On the basis of type, the antimicrobial susceptibility testing market is segmented into antibacterial testing, antifungal testing and others.
In 2021, antibacterial testing segment is expected to dominate the market due to wide number of tests available in the market.Key Players of North America Antimicrobial Susceptibility Testing MarketBD, Synbiosis, Zhuhai DL Biotech Co., Ltd, Mast Group Ltd., HiMedia Laboratories, Accelerate Diagnostics, Inc., Liofilchem S.r.l., Alifax S.r.l., MERLIN Gesellschaft für mikrobiologische Diagnostika mbH, bioMérieux SA, NuMedii, Inc., BacterioScan, Inc., Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., Creative Diagnostics, Genefluidics, Inc., Rosco Diagnostica A/S, ERBA Group, Merck KGaA, DanaherMAJOR TOC OF THE REPORTPart One: Antimicrobial Susceptibility Testing Market OverviewPart Two: Manufacturers ProfilesPart Three: North America Antimicrobial Susceptibility Testing Market Competition, by PlayersPart Four: North America Antimicrobial Susceptibility Testing Market Size by RegionsPart Five: North America Antimicrobial Susceptibility Testing Market Revenue by CountriesPart Six: North America Antimicrobial Susceptibility Testing Market Revenue by Product Type (Instruments, Consumables & Accessories and Services & Software)Part Seven: North America Antimicrobial Susceptibility Testing Market Revenue by Methods (Mass Spectrometry Method, Dilution, Disk Diffusion, E-Test, Genotypic Methods and Others)Part Eight: North America Antimicrobial Susceptibility Testing Market Revenue by Type (Antibacterial Testing, Antifungal Testing and Others)Part Nine: North America Antimicrobial Susceptibility Testing Market Revenue by Application (Clinical Diagnostics, Drug Discovery and Development, Epidemiology and Others)Part Ten: North America Antimicrobial Susceptibility Testing Market Revenue by End User (Hospitals, Pharmaceuticals and Biotechnology Companies, Diagnostic Laboratories, Contract Research Organizations, Research Centres & Academic Institutes and Others)Part Eleven: North America Antimicrobial Susceptibility Testing Market Revenue by Distribution Channel (Direct Sales, Retail Sales and Third Party Distributor)Get Detail TOC@ https://www.databridgemarketresearch.com/toc/?dbmr=north-america-antimicrobial-susceptibility-testing-marketAntimicrobial Susceptibility TestingKey Report HighlightsComprehensive pricing analysis based on different product types and regional segmentsMarket size data in terms of revenue and sales volumeDeep insights about regulatory and investment scenarios of the North America Antimicrobial Susceptibility Testing MarketAnalysis of market effect factors and their impact on the forecast and outlook of the North America Antimicrobial Susceptibility Testing MarketThe detailed assessment of the vendor landscape and leading companies to help understand the level of competition in the North America Antimicrobial Susceptibility Testing MarketA roadmap of growth opportunities available in the North America Antimicrobial Susceptibility Testing Marketwith the identification of key factorsThe exhaustive analysis of various trends of the North America Antimicrobial Susceptibility Testing Marketto help identify market developmentsKey Questions Answered in Report:What is the key to the Antimicrobial Susceptibility Testing Market?What will the Antimicrobial Susceptibility Testing Market Demand and what will be Growth?What are the latest opportunities for Antimicrobial Susceptibility Testing Market in the future?What are the strengths of the key players?Access Full Report @ https://www.databridgemarketresearch.com/reports/north-america-antimicrobial-susceptibility-testing-marketAbout Us:Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches.
We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the marketContact:Data Bridge Market ResearchTel: +1-888-387-2818Email: [email protected] Related Reports@Drug Safety Solutions and Pharmacovigilance MarketVitamins MarketRadiology Services Market
Antimicrobial Susceptibility Testing Market is expected to gain market growth in the forecast period of 2020 to 2027.
Data Bridge Market Research analyses the market to account to USD 4.50 billion by 2027 growing at a CAGR of 5.15% in the above-mentioned forecast period.
The growing prevalence of infectious disease will help in driving the growth of the antimicrobial susceptibility testing market.Increased funding, research grants and public-private investments, technological advancements towards the development of rapid testing methods will likely to accelerate the growth of the antimicrobial susceptibility testing market in the forecast period of 2020-2027.
On the other hand, emergence of multidrug resistance due to drug abuse will further boost various opportunities that will lead to the growth of the antimicrobial susceptibility testing market in the above mentioned forecast period.Get Exclusive Sample Report: @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-antimicrobial-susceptibility-testing-market Scope of the Antimicrobial Susceptibility Testing MarketCurrent and future of Antimicrobial Susceptibility Testing Market outlook in the developed and emerging marketsThe segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast periodRegions/Countries that are expected to witness the fastest growth rates during the forecast periodThe latest developments, market shares, and strategies that are employed by the major market playersGlobal Antimicrobial Susceptibility Testing Market By Product (Automated Laboratory Instruments, Susceptibility Testing Disks), Methods (Dilution, Disk Diffusion, E-test & Others), Type (Antibacterial Testing, Antifungal Testing), Application (Clinical Diagnostics, Epidemiology), End User (Diagnostic Centers and Hospitals, Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CROs), Research and Academic Institutes), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2027 Browse Related Report Here:Metabolic Testing MarketBlood Screening MarketSome of the leading key players profiled in this study:The major players covered in the antimicrobial susceptibility testing market report are bioMérieux SA, Danaher, BD, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., Liofilchem S.r.l., Accelerate Diagnostics, Inc., Alifax S.r.l., Creative Diagnostics., Merck KGaA, Synbiosis and Zhuhai DL Biotech Co., Ltd among other domestic and global players.
Market share data is available for global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately.
DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
According to the new market research report Antimicrobial Susceptibility Testing Market by Product (Manual, Automated Susceptibility Testing System), Type (Antibacterial, Antifungal), Application (Clinical Diagnostics), Method (ETEST, Disk Diffusion), End-User - Global Forecasts to 2025, published by MarketsandMarkets™, the Antimicrobial Susceptibility Testing Market is projected to reach USD 4.2 billion by 2025 from USD 3.2 billion in 2020, at a CAGR of 5.5% during the forecast period.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=206359984 The growth of the antibacterial susceptibility testing systems market is mainly driven by the growing number of hospitals across major markets, increasing awareness about diagnosis and the treatment of hospital-acquired infections coupled with the increasing adoption of rapid AST methods.
Moreover, rising R investments by the key players operating in the market to develop genetics and genotyping-based AST solutions coupled with growing funding & grants for AST-related research are other important factors to drive the market growth in the near future.
Among the manual antimicrobial susceptibility testing products, the susceptibility testing disks segment held a major share of the market in 2019.
The high quality, low cost, and ease of use of these products are increasing the adoption of susceptibility testing disks in emerging countries.
Some prominent players offering susceptibility testing disks include BD (US), Thermo Fisher Scientific, Inc. (US), Bio-Rad Laboratories, Inc. (US), and HiMedia Laboratories (India).
Antibacterial drugs are playing the important role in the prevention of infectious diseases, however, the cases of drug misuse and overuse, led to the development of drug resistance.
This is putting pressure on the key players to manufacture the test kits which gives accurate and effective results to better treat the patients.Antimicrobial susceptibility testing (AST) is a laboratory procedure which is used to determine which antimicrobial impedes the growth of bacteria, fungi, and other microorganism causing a specific infection.
The report also recognizes and analyses the rising trends along with major drivers, challenges and opportunities in the market.
This Asia-Pacific Antimicrobial Susceptibility Testing Market report provides major statistics on the market status of global and regional manufacturers and is a helpful source of assistance and direction for companies and individuals interested in Healthcare industry.
In 2021, instruments segment is expected to dominate the market due to high technology adoption by key players in the market.On the basis of methods, the antimicrobial susceptibility testing market is segmented into mass spectrometry method, dilution, disk diffusion, e-test, genotypic methods, and others.
Manufacturers are developing large number of instruments for bacterial testing.On the basis of application, the antimicrobial susceptibility testing market is segmented into clinical diagnostics, drug discovery and development, epidemiology and others.
Growth in the market is largely driven by the growing threat of antimicrobial resistance due to the overuse of antibiotics, rising demand for animal-derived products, growing prevalence of zoonotic diseases, rising demand for pet insurance, growing animal health expenditure, and the growing number of veterinary practitioners & their rising income levels in developed economies.
The rising focus on veterinary antimicrobial susceptibility testing in emerging markets due to supportive government initiatives and awareness initiatives for antimicrobial resistance and control offer significant growth opportunities for the market players.The Veterinary Antimicrobial Susceptibility Testing Market is expected to reach USD 135 million by 2026 from an estimated USD 100 million in 2021, at a CAGR of 6.1%.Ask For PDF Brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=50401056Since the beginning of 2020, the majority of the countries worldwide shut down their borders and limited transportation in a bid to contain the coronavirus (COVID-19) outbreak, thus, creating impediments for international trade and transportation.The food-producing animal segment is expected to account for the largest share of the veterinary AST marketBased on animal type, the veterinary antimicrobial susceptibility testing market is segmented into food-producing animals and companion animals.
The food-producing animals segment accounted for the largest share of the market in 2020.
The large share and high growth of this segment can be attributed to the high use of antibiotics in food-producing animals, increasing incidence of antimicrobial resistance, increasing demand for meat and dairy products, rising animal healthcare expenditure in developed countries, and the increasing incidence of disease outbreaks in food-producing animals.
Companion animals are further segmented into dogs, cats, horses, and other companion animals.The culture media segment is expected to grow at the highest rate during the forecast periodThe culture media segment is expected to register the highest growth rate during the forecast period.
Growth in this product segment can be attributed to the constant requirement and recurrent purchase of these products for cultivating bacterial isolates under controlled environmental laboratory conditions.The veterinary reference laboratory end-user segment is expected to account for the largest share of the veterinary AST marketBased on end users, the veterinary antimicrobial susceptibility testing market is segmented into veterinary reference laboratories, veterinary research institutes and universities, and other end users.
Antibacterial drugs are playing the important role in the prevention of infectious diseases, however, the cases of drug misuse and overuse, led to the development of drug resistance.
This is putting pressure on the key players to manufacture the test kits which gives accurate and effective results to better treat the patients.Antimicrobial susceptibility testing (AST) is a laboratory procedure which is used to determine which antimicrobial impedes the growth of bacteria, fungi, and other microorganism causing a specific infection.
The results of this test can help healthcare professionals to get access to better clinical diagnosis and select the drug that is most likely to be effective in treating that particular infection.Antimicrobial susceptibility testing market is expected to gain market growth in the forecast period of 2021 to 2028.
The report also recognizes and analyses the rising trends along with major drivers, challenges and opportunities in the market.
This Asia-Pacific Antimicrobial Susceptibility Testing Market report provides major statistics on the market status of global and regional manufacturers and is a helpful source of assistance and direction for companies and individuals interested in Healthcare industry.
In 2021, instruments segment is expected to dominate the market due to high technology adoption by key players in the market.On the basis of methods, the antimicrobial susceptibility testing market is segmented into mass spectrometry method, dilution, disk diffusion, e-test, genotypic methods, and others.
The global Veterinary Antimicrobial Susceptibility Testing Market research report, published by Value Market Research, is designed to offer various market framework such as market size, portion, trends, growth path, value and factors that impact the current market dynamics over the forecast period 2020-2027.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.
This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
Get more information on "Global Veterinary Antimicrobial Susceptibility Testing Market Research Report" by requesting FREE Sample Copy at https://www.valuemarketresearch.com/contact/veterinary-antimicrobial-susceptibility-testing-market/download-sample Market Dynamics The growing awareness about infections among companion animals and livestock is the primary impetus for market growth.
The prevalence of zoonotic diseases among the global population and the need to identify the right choice or dosage of antibiotics in treating the same will benefit market growth.
The increased use of antimicrobial susceptibility test kits in the pharmaceutical and biotechnology sectors in the research & development of novel drugs to fight bacteria will further enhance the market growth.
Growth in the market is largely driven by the growing threat of antimicrobial resistance due to the overuse of antibiotics, rising demand for animal-derived products, growing prevalence of zoonotic diseases, rising demand for pet insurance, growing animal health expenditure, and the growing number of veterinary practitioners & their rising income levels in developed economies.
The rising focus on veterinary antimicrobial susceptibility testing in emerging markets due to supportive government initiatives and awareness initiatives for antimicrobial resistance and control offer significant growth opportunities for the market players.The Veterinary Antimicrobial Susceptibility Testing Market is expected to reach USD 135 million by 2026 from an estimated USD 100 million in 2021, at a CAGR of 6.1%.Ask For PDF Brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=50401056Since the beginning of 2020, the majority of the countries worldwide shut down their borders and limited transportation in a bid to contain the coronavirus (COVID-19) outbreak, thus, creating impediments for international trade and transportation.The food-producing animal segment is expected to account for the largest share of the veterinary AST marketBased on animal type, the veterinary antimicrobial susceptibility testing market is segmented into food-producing animals and companion animals.
The food-producing animals segment accounted for the largest share of the market in 2020.
The large share and high growth of this segment can be attributed to the high use of antibiotics in food-producing animals, increasing incidence of antimicrobial resistance, increasing demand for meat and dairy products, rising animal healthcare expenditure in developed countries, and the increasing incidence of disease outbreaks in food-producing animals.
Companion animals are further segmented into dogs, cats, horses, and other companion animals.The culture media segment is expected to grow at the highest rate during the forecast periodThe culture media segment is expected to register the highest growth rate during the forecast period.
Growth in this product segment can be attributed to the constant requirement and recurrent purchase of these products for cultivating bacterial isolates under controlled environmental laboratory conditions.The veterinary reference laboratory end-user segment is expected to account for the largest share of the veterinary AST marketBased on end users, the veterinary antimicrobial susceptibility testing market is segmented into veterinary reference laboratories, veterinary research institutes and universities, and other end users.
On the basis of product type, the antimicrobial susceptibility testing market is segmented into instruments, consumables & accessories and services & software.
In 2021, instruments segment is expected to dominate the market due to high technology adoption by key players in the market.On the basis of methods, the antimicrobial susceptibility testing market is segmented into mass spectrometry method, dilution, disk diffusion, e-test, genotypic methods and others.
In 2021, disk diffusion segment is expected to dominate the market due to its accurate, reliable and efficient results.On the basis of type, the antimicrobial susceptibility testing market is segmented into antibacterial testing, antifungal testing and others.
In 2021, antibacterial testing segment is expected to dominate the market due to wide number of tests available in the market.Key Players of North America Antimicrobial Susceptibility Testing MarketBD, Synbiosis, Zhuhai DL Biotech Co., Ltd, Mast Group Ltd., HiMedia Laboratories, Accelerate Diagnostics, Inc., Liofilchem S.r.l., Alifax S.r.l., MERLIN Gesellschaft für mikrobiologische Diagnostika mbH, bioMérieux SA, NuMedii, Inc., BacterioScan, Inc., Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., Creative Diagnostics, Genefluidics, Inc., Rosco Diagnostica A/S, ERBA Group, Merck KGaA, DanaherMAJOR TOC OF THE REPORTPart One: Antimicrobial Susceptibility Testing Market OverviewPart Two: Manufacturers ProfilesPart Three: North America Antimicrobial Susceptibility Testing Market Competition, by PlayersPart Four: North America Antimicrobial Susceptibility Testing Market Size by RegionsPart Five: North America Antimicrobial Susceptibility Testing Market Revenue by CountriesPart Six: North America Antimicrobial Susceptibility Testing Market Revenue by Product Type (Instruments, Consumables & Accessories and Services & Software)Part Seven: North America Antimicrobial Susceptibility Testing Market Revenue by Methods (Mass Spectrometry Method, Dilution, Disk Diffusion, E-Test, Genotypic Methods and Others)Part Eight: North America Antimicrobial Susceptibility Testing Market Revenue by Type (Antibacterial Testing, Antifungal Testing and Others)Part Nine: North America Antimicrobial Susceptibility Testing Market Revenue by Application (Clinical Diagnostics, Drug Discovery and Development, Epidemiology and Others)Part Ten: North America Antimicrobial Susceptibility Testing Market Revenue by End User (Hospitals, Pharmaceuticals and Biotechnology Companies, Diagnostic Laboratories, Contract Research Organizations, Research Centres & Academic Institutes and Others)Part Eleven: North America Antimicrobial Susceptibility Testing Market Revenue by Distribution Channel (Direct Sales, Retail Sales and Third Party Distributor)Get Detail TOC@ https://www.databridgemarketresearch.com/toc/?dbmr=north-america-antimicrobial-susceptibility-testing-marketAntimicrobial Susceptibility TestingKey Report HighlightsComprehensive pricing analysis based on different product types and regional segmentsMarket size data in terms of revenue and sales volumeDeep insights about regulatory and investment scenarios of the North America Antimicrobial Susceptibility Testing MarketAnalysis of market effect factors and their impact on the forecast and outlook of the North America Antimicrobial Susceptibility Testing MarketThe detailed assessment of the vendor landscape and leading companies to help understand the level of competition in the North America Antimicrobial Susceptibility Testing MarketA roadmap of growth opportunities available in the North America Antimicrobial Susceptibility Testing Marketwith the identification of key factorsThe exhaustive analysis of various trends of the North America Antimicrobial Susceptibility Testing Marketto help identify market developmentsKey Questions Answered in Report:What is the key to the Antimicrobial Susceptibility Testing Market?What will the Antimicrobial Susceptibility Testing Market Demand and what will be Growth?What are the latest opportunities for Antimicrobial Susceptibility Testing Market in the future?What are the strengths of the key players?Access Full Report @ https://www.databridgemarketresearch.com/reports/north-america-antimicrobial-susceptibility-testing-marketAbout Us:Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches.
We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the marketContact:Data Bridge Market ResearchTel: +1-888-387-2818Email: [email protected] Related Reports@Drug Safety Solutions and Pharmacovigilance MarketVitamins MarketRadiology Services Market
Antibacterial drugs are playing the important role in the prevention of infectious diseases, however, the cases of drug misuse and overuse, led to the development of drug resistance.
This is putting pressure on the key players to manufacture the test kits which gives accurate and effective results to better treat the patients.Antimicrobial susceptibility testing (AST) is a laboratory procedure which is used to determine which antimicrobial impedes the growth of bacteria, fungi, and other microorganism causing a specific infection.
The results of this test can help healthcare professionals to get access to better clinical diagnosis and select the drug that is most likely to be effective in treating that particular infection.Antimicrobial susceptibility testing market is expected to gain market growth in the forecast period of 2021 to 2028.
The report also recognizes and analyses the rising trends along with major drivers, challenges and opportunities in the market.
This Asia-Pacific Antimicrobial Susceptibility Testing Market report provides major statistics on the market status of global and regional manufacturers and is a helpful source of assistance and direction for companies and individuals interested in Healthcare industry.
In 2021, instruments segment is expected to dominate the market due to high technology adoption by key players in the market.On the basis of methods, the antimicrobial susceptibility testing market is segmented into mass spectrometry method, dilution, disk diffusion, e-test, genotypic methods, and others.
Antimicrobial Susceptibility Testing Market is expected to gain market growth in the forecast period of 2020 to 2027.
Data Bridge Market Research analyses the market to account to USD 4.50 billion by 2027 growing at a CAGR of 5.15% in the above-mentioned forecast period.
The growing prevalence of infectious disease will help in driving the growth of the antimicrobial susceptibility testing market.Increased funding, research grants and public-private investments, technological advancements towards the development of rapid testing methods will likely to accelerate the growth of the antimicrobial susceptibility testing market in the forecast period of 2020-2027.
On the other hand, emergence of multidrug resistance due to drug abuse will further boost various opportunities that will lead to the growth of the antimicrobial susceptibility testing market in the above mentioned forecast period.Get Exclusive Sample Report: @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-antimicrobial-susceptibility-testing-market Scope of the Antimicrobial Susceptibility Testing MarketCurrent and future of Antimicrobial Susceptibility Testing Market outlook in the developed and emerging marketsThe segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast periodRegions/Countries that are expected to witness the fastest growth rates during the forecast periodThe latest developments, market shares, and strategies that are employed by the major market playersGlobal Antimicrobial Susceptibility Testing Market By Product (Automated Laboratory Instruments, Susceptibility Testing Disks), Methods (Dilution, Disk Diffusion, E-test & Others), Type (Antibacterial Testing, Antifungal Testing), Application (Clinical Diagnostics, Epidemiology), End User (Diagnostic Centers and Hospitals, Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CROs), Research and Academic Institutes), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2027 Browse Related Report Here:Metabolic Testing MarketBlood Screening MarketSome of the leading key players profiled in this study:The major players covered in the antimicrobial susceptibility testing market report are bioMérieux SA, Danaher, BD, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., Liofilchem S.r.l., Accelerate Diagnostics, Inc., Alifax S.r.l., Creative Diagnostics., Merck KGaA, Synbiosis and Zhuhai DL Biotech Co., Ltd among other domestic and global players.
Market share data is available for global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately.
DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
According to the new market research report Antimicrobial Susceptibility Testing Market by Product (Manual, Automated Susceptibility Testing System), Type (Antibacterial, Antifungal), Application (Clinical Diagnostics), Method (ETEST, Disk Diffusion), End-User - Global Forecasts to 2025, published by MarketsandMarkets™, the Antimicrobial Susceptibility Testing Market is projected to reach USD 4.2 billion by 2025 from USD 3.2 billion in 2020, at a CAGR of 5.5% during the forecast period.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=206359984 The growth of the antibacterial susceptibility testing systems market is mainly driven by the growing number of hospitals across major markets, increasing awareness about diagnosis and the treatment of hospital-acquired infections coupled with the increasing adoption of rapid AST methods.
Moreover, rising R investments by the key players operating in the market to develop genetics and genotyping-based AST solutions coupled with growing funding & grants for AST-related research are other important factors to drive the market growth in the near future.
Among the manual antimicrobial susceptibility testing products, the susceptibility testing disks segment held a major share of the market in 2019.
The high quality, low cost, and ease of use of these products are increasing the adoption of susceptibility testing disks in emerging countries.
Some prominent players offering susceptibility testing disks include BD (US), Thermo Fisher Scientific, Inc. (US), Bio-Rad Laboratories, Inc. (US), and HiMedia Laboratories (India).
The global Veterinary Antimicrobial Susceptibility Testing Market research report, published by Value Market Research, is designed to offer various market framework such as market size, portion, trends, growth path, value and factors that impact the current market dynamics over the forecast period 2020-2027.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.
This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
Get more information on "Global Veterinary Antimicrobial Susceptibility Testing Market Research Report" by requesting FREE Sample Copy at https://www.valuemarketresearch.com/contact/veterinary-antimicrobial-susceptibility-testing-market/download-sample Market Dynamics The growing awareness about infections among companion animals and livestock is the primary impetus for market growth.
The prevalence of zoonotic diseases among the global population and the need to identify the right choice or dosage of antibiotics in treating the same will benefit market growth.
The increased use of antimicrobial susceptibility test kits in the pharmaceutical and biotechnology sectors in the research & development of novel drugs to fight bacteria will further enhance the market growth.
Antibacterial drugs are playing the important role in the prevention of infectious diseases, however, the cases of drug misuse and overuse, led to the development of drug resistance.
This is putting pressure on the key players to manufacture the test kits which gives accurate and effective results to better treat the patients.Antimicrobial susceptibility testing (AST) is a laboratory procedure which is used to determine which antimicrobial impedes the growth of bacteria, fungi, and other microorganism causing a specific infection.
The report also recognizes and analyses the rising trends along with major drivers, challenges and opportunities in the market.
This Asia-Pacific Antimicrobial Susceptibility Testing Market report provides major statistics on the market status of global and regional manufacturers and is a helpful source of assistance and direction for companies and individuals interested in Healthcare industry.
In 2021, instruments segment is expected to dominate the market due to high technology adoption by key players in the market.On the basis of methods, the antimicrobial susceptibility testing market is segmented into mass spectrometry method, dilution, disk diffusion, e-test, genotypic methods, and others.
Manufacturers are developing large number of instruments for bacterial testing.On the basis of application, the antimicrobial susceptibility testing market is segmented into clinical diagnostics, drug discovery and development, epidemiology and others.